Inhibition of TRPM2 channel activity in macrophages decreases the production of ROS and pro-inflammatory cytokines, and reduces the size of atherosclerotic lesions in multiple mice models of atherosclerosis (28, 52). Here, TRPM2 is linked to atherosclerosis.